Prostate cancer patients who receive permanent radiotherapy implants twice as likely to be free of cancer after five years

Results from a randomised controlled trial to compare the use of permanent radioactive implants (brachytherapy) with dose-escalated external beam radiotherapy in patients with prostate cancer show that the men who received brachytherapy were twice as likely to be cancer-free five years later.

Read the whole article on Science Daily

More from Science Daily